NIH-funded research R01 grant

Multisensory Early Oral Human Milk for Very Preterm Infants

Official title: Randomized Controlled Trial of Multisensory Early Oral Administration of Human Milk (M-MILK) for Very Preterm Infants: Enhancing Stress Regulation, Neurodevelopment, and Oral Feeding Skills

Funded at Loyola University Chicago · NIH-11413402 · Data updated 2026-11-12

A randomized trial tests giving tiny drops of human milk in a multisensory way to very preterm babies starting on day 3 to support stress regulation, brain development, and easier oral feeding.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLoyola University Chicago
NIH-funded
Lab location1 site (Maywood, United States)
Project startSeptember 10, 2025
Project endMay 31, 2030
Funding year2026
Award (this year)$506,859
NIH project number5R01HD119077-02
Project IDNIH-11413402 on NIH RePORTER

Who could benefit from this research

Could help

Very preterm infants less than 32 weeks gestation in NICUs, whose guardians consent to participate.

Less likely to help

Infants who do not respond to the intervention or have contraindications to breast milk or oral feeds may not benefit.

What this research studies

Very premature babies face high risks of neurodevelopmental problems and oral feeding difficulties. This study tests a new NICU intervention called M-MILK, where tiny droplets of breast milk are given in a multisensory way to help infants regulate stress and improve feeding skills. The intervention starts on day 3 and compares to standard care to see effects on stress biomarkers, brain development, and feeding outcomes. If successful, this approach could shorten NICU stays and improve long-term development for these vulnerable infants.

Why it matters

Potential benefit: If successful, infants may experience better stress regulation, faster transition to full oral feeding, and improved neurodevelopment.

How similar studies have gone: Preliminary data suggest potential benefits of early oral milk and multisensory feeding, but randomized evidence in this exact approach is limited.

Where this research is happening

  • Loyola University Chicago
    Maywood, United States
    Active

Researchers

  • Principal investigator: Griffith, Thao T — Loyola University Chicago
  • Study coordinator: Griffith, Thao T

Related research

Other NIH-funded projects on the same topics.

  • Using CPAP therapy to help lung growth in preterm infants

    This study is looking at whether keeping stable preterm babies on CPAP breathing support for two extra weeks can help their lungs grow better and work more effectively, so they can breathe easier as they grow.

    NIH research Oregon Health & Science University · Portland, United States · NIH-10683051

  • Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure

    A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.

    NIH research Pennsylvania State Univ Hershey Med Ctr · Hershey, United States · NIH-11635771

  • Screening and treatment of Chlamydia infection in pregnancy to help prevent preterm birth

    This grant studies whether screening pregnant people for Chlamydia trachomatis and treating those who are positive can reduce the risk of preterm birth.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11617691

  • Shorter antifungal treatment for kids with candidemia

    A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606539

  • Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia

    This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606535

  • Shorter antifungal treatment for kids with candidemia

    A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606531

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.